KIR/KIR-ligand genotypes and clinical outcomes following chemoimmunotherapy in patients with relapsed or refractory neuroblastoma: A report from the Children's Oncology Group
- Amy K. Erbe*
- , Mitch B. Diccianni
- , Rajen Mody
- , Arlene Naranjo
- , Fan F. Zhang
- , Jen Birstler
- , Kyungmann Kim
- , Arika S. Feils
- , Jung Tung Hung
- , Wendy B. London
- , Barry L. Shulkin
- , Varsha Mathew
- , Marguerite T. Parisi
- , Sabah Servaes
- , Shahab Asgharzadeh
- , John M. Maris
- , Julie Park
- , Alice L. Yu
- , Paul M. Sondel
- , Rochelle Bagatell
*Corresponding author for this work
- University of Wisconsin-Madison
- University of California at San Diego
- University of Michigan, Ann Arbor
- University of Florida
- CureSearch
- Chang Gung Memorial Hospital
- Dana-Farber Cancer Institute
- St. Jude Children Research Hospital
- Seattle Children's Hospital
- The Children's Hospital of Philadelphia
- Children's Hospital Los Angeles
Research output: Contribution to journal › Journal Article › peer-review
19
Scopus
citations